uniQure N.V. (NASDAQ: QURE): The Best-Of-Breed For Investing?

SSgA Funds Management, Inc. recently announced the acquisition of new stake in uniQure N.V. (NASDAQ:QURE). The institutional investor has increased its shareholding in the Healthcare company by 35.75% to 3.45 million shares with purchase of 0.91 million shares. This fresh investment now brings its stake to 7.22% valued currently at $23.39 million. In addition, Nantahala Capital Management LLC raised its holdings by 0.17 million to 3.02 million shares. And Morgan Stanley & Co. LLC has lifted its position by 131.40% or 1.49 million shares – to 2.63 million shares.

Currently, there are 46.97M common shares owned by the public and among those 42.52M shares have been available to trade.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 19 of these insider trades were purchases, accounting for 390,750 shares. Insider sales of the common stock occurred on 37 occasions, with total insider shares sold totaling 115,059 shares.

The top 3 mutual fund holders in uniQure N.V. are SPDR S&P Biotech ETF, Worldwide Healthcare Trust Plc, and Government Pension Fund – Global. SPDR S&P Biotech ETF owns 3.43 million shares of the company’s stock, all valued at over $23.29 million. The company bought an additional 16005.0 shares recently to bring their total holdings to about 7.18% of the shares outstanding. Government Pension Fund – Global bought 0.36 million shares to bring its total holdings to over 0.77 million shares at a value of $5.24 million. Government Pension Fund – Global now owns shares totaling to 1.62% of the shares outstanding.

However, the script later moved the day high at 8.00, down -16.79%. The company’s stock has a 5-day price change of -7.13% and -11.11% over the past three months. QURE shares are trading -70.71% year to date (YTD), with the 12-month market performance down to -71.27% lower. It has a 12-month low price of $5.49 and touched a high of $24.19 over the same period. QURE has an average intraday trading volume of 1.16 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.66%, 0.23%, and -46.96% respectively.

Institutional ownership of uniQure N.V. (NASDAQ: QURE) shares accounts for 73.75% of the company’s 46.97M shares outstanding. Mutual fund holders own 29.10%, while other institutional holders and individual stakeholders account for 45.13% and 12.70% respectively.

It has a market capitalization of $317.46M and a beta (3y monthly) value of 1.11. The earnings-per-share (ttm) stands at -$4.80. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.54% over the week and 7.28% over the month.

Analysts forecast that uniQure N.V. (QURE) will achieve an EPS of -$1.43 for the current quarter, -$1.26 for the next quarter and -$4.01 for 2024. The lowest estimate earnings-per-share for the quarter is -$1.89 while analysts give the company a high EPS estimate of -$0.61. Comparatively, EPS for the current quarter was $0.14 a year ago. Earnings per share for the fiscal year are expected to decrease by -132.89%, and 36.22% over the next financial year.

Looking at the support for the QURE, a number of firms have released research notes about the stock. Mizuho stated their Neutral rating for the stock in a research note on Dec-20-23, with the firm’s price target at $52-$10.

Most Popular

Related Posts